General Information
Product name
Fentanyl Citrate Injection, USP
Manufacturer Name
Hospital Products Division
Emergency telephone
1-847-937-7970, 1-800-424-9300
Icons in SDS
Company Information
company name
Hospital Products Division
Section 2
Principle Routes of Exposure
Skin: Unlikely Inhalation: Unlikely 3. HAZARDS INFORMATION, continued ----------------------- Ingestion: Unlikely INGESTION RATING: Possibly highly toxic SKIN ABSORPTION RATING: N/D INHALATION RATING: N/D CORROSIVENESS RATING: N/D SKIN CONTACT RATING: N/D SKIN SENSITIZATION RATING: N/D EYE CONTACT RATING: N/D TARGET ORGANS: Central nervous system, lungs, fetus, eyes, cardiovascular system CARCINOGENICITY RATING NTP N/L IARC N/L OSHA N/L ACGIH: N/L None SIGNS AND SYMPTOMS: Clinically, overexposure can produce respiratory depression (breathing difficulties), reduced heart rate and muscle rigidity. Other adverse reactions include changes in blood pressure, dizziness, blurred vision, nausea, emesis, laryngospasm and perspiration. Opioid analgesics produce euphoria, miosis (constriction of pupils), reduced heart rate and bronchoconstriction. Overdose produces the same effects which if not treated can lead to cessation of breathing, unconsciousness and cardiac arrest. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Data suggest conditions associated with impaired respiration, liver or kidney dysfunction, heart disease and concurrent use of central nervous system depressant drugs.